Off–Label Drugs Market Analysis for United States

“United States Off–Label Drugs Market & Forecast” report provides a comprehensive analysis of the emerging Off–Label Drugs market. The report also entails commonly prescribed Off–Label Drugs, Perspective of Physicians, Patients, Pharmaceutical Companies and Regulatory Authorities, Off–label Promotion Settlements under the False Claims Act. The report also studies Drivers and Challenges of United States Off–Label Drugs market. This 67 page report with 16 Figures and

The 6 Off–Label Drugs Segment Covered in the Report are as Follows:

• Cancer Off–Label Drugs

• Central Nervous System (CNS) Off–Label Drugs

• Anti–Ashmatics Off–Label Drugs

• Anti–Allergies Off–Label Drugs

• Anti–Hypertensives Off–Label Drugs

• Anti–Infectives Off–Label Drugs

Purchase a Copy of this Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=349167 .

Table of Contents

1. Executive Summary

2. United States Off–Label Drugs Market & Forecast

3. United States Off–Label Drugs Market Share & Forecast

4. United States Off–Label Drugs Market – Segment wise

4.1 United States – Cancer Off–Label Drugs Market & Forecast

4.2 United States – Central Nervous System (CNS) Off–Label Drugs Market & Forecast

4.3 United States – Anti–Ashmatics Off–Label Drugs Market & Forecast

4.4 United States – Anti–Allergies Off–Label Drugs Market & Forecast

4.5 United States – Anti–Hypertensives Off–Label Drugs Market & Forecast

4.6 United States – Anti–Infectives Off–Label Drugs Market & Forecast

5. Drugs Commonly Prescribed Off–Label

6. Off–Label Use of Medicine & Different Perspectives

6.1 Physicians Perspective

6.1.1 Physicians’ Liability for Off–Label Prescriptions

6.2 Patients Perspective

6.3 Perspective of the Pharmaceutical Companies

6.4 Perspective of Regulatory Agencies

7. Off–Label Promotion Settlements Under The False Claims Act

7.1 Year 2004

7.2 Year 2005

7.3 Year 2006

7.4 Year 2007

7.5 Year 2008

7.6 Year 2009

7.7 Year 2010

7.8 Year 2011

7.9 Year...